Stephens Consulting, LLC Intellia Therapeutics, Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 45 shares of NTLA stock, worth $325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$325% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
334Shares Held
95.3MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$90.6 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$73.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$69.4 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$37.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$27.6 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $550M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...